Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL)

Haematologica. 1985 Jan-Feb;70(1):39-43.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Acute Disease
  • Aminoacridines / administration & dosage
  • Aminoacridines / therapeutic use*
  • Aminoacridines / toxicity
  • Amsacrine
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Azacitidine / administration & dosage*
  • Clinical Trials as Topic
  • Etoposide / administration & dosage*
  • Humans
  • Leukemia / drug therapy*
  • Podophyllotoxin / analogs & derivatives*

Substances

  • Aminoacridines
  • Antineoplastic Agents
  • Amsacrine
  • Etoposide
  • Podophyllotoxin
  • Azacitidine